Oliver Schacht | President and Chief Executive Officer |
Tim Dec | Chief Financial Officer |
Max Jacobs | Edison Group |
Ben Haynor | Alliance Global Partners |
Welcome to the OpGen Fourth Quarter and Full Year 2020 Earnings Call and Business Update. At this time, all participants are in listen-only mode.
Following management’s prepared remarks, there will be a Q&A session.
As a reminder, this conference call is being recorded today, March 25, 2021.
Before we begin, I would like to caution you that comments made during this conference call by management may contain forward-looking statements regarding the operations of and future results of OpGen, including its subsidiary Curetis and Ares Genetics.